Clinical Trials Logo

Clinical Trial Summary

By using three different Gastric Preparation of Magnetic-controlled Capsule Endoscopy, the investigators hope to find out the optimal gastric preparation plan.


Clinical Trial Description

It is a prospective, single-blind, randomized controlled trial. Patients who were conducted by Magnetic-controlled Capsule Endoscopy at Changhai Hospital will be randomly allocated into three different Gastric Preparation group before the procedure. It include clear water group which patient only drink 1000ml clear water before checking; simethicone group which patient drink 950ml clear water and 15ml simethicone before checking; simethicone combined with pronase group which patient drink 900ml lear water and 15ml simethicone and 20,000iu pronase before checking. The result were got from a relevant professional physician's blinded independent image-reading. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT02846155
Study type Interventional
Source Changhai Hospital
Contact Zhuan Liao
Email liaozhuan@smmu.edu.cn
Status Recruiting
Phase Phase 2
Start date May 2016
Completion date December 2016

See also
  Status Clinical Trial Phase
Recruiting NCT05069233 - Magnetically Controlled Capsule Endoscopy in Visualization of the UGI and Small Intestine
Completed NCT00745459 - Phase III General Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy Phase 3
Active, not recruiting NCT05602935 - Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study Phase 2
Completed NCT03549494 - Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction Phase 2
Completed NCT00977678 - Drop in Gastroscopy - Experience After 9 Months N/A
Terminated NCT00577772 - Transit Time and Bacterial Overgrowth Using SmartPill Capsule N/A
Completed NCT03514966 - Repetitive Position Change Improves Gastric Cleanliness for MCE N/A
Not yet recruiting NCT03889626 - The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer Phase 3
Active, not recruiting NCT02476097 - PROGRESSive Withdrawal Esomeprazole and Acid-related Symptoms Phase 4
Completed NCT01576380 - A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients Phase 2
Completed NCT00682877 - A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time - Over 65 Years Old N/A
Completed NCT00128284 - A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time N/A
Completed NCT01420588 - Diagnosis of Gastric Lesions From Exhaled Breath and Saliva